insights_auto
524494 주가가 하락한 이유: 3.51%?
자세히 알아보기chevron_right
524494:BOM
IPCA Laboratories Ltd
₹1,845.00
arrow_downward
-3.51%(-67.20) 1D
10월 16일, 오후 3시 30분 0초 GMT+5:30 · INR
search
모든 종목 코드
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_auto524494의 주요 통계 생성 중...
시가
₹1,913.95
고가
₹1,913.95
저가
₹1,812.60
시가총액
4682.11억
평균 거래량
2.79만
거래량
1.20만
배당금
0.33%
분기 배당금
₹1.50
배당락일
2026. 8. 7.
주가수익률
35.74
52주 최고가
₹2,039.30
52주 최저가
₹1,252.95
EPS
₹51.63
유통 주식수
1.26억
직원 수
2만
시가
₹1,913.95
고가
₹1,913.95
저가
₹1,812.60
시가총액
4682.11억
평균 거래량
2.79만
거래량
1.20만
배당금
0.33%
분기 배당금
₹1.50
배당락일
2026. 8. 7.
주가수익률
35.74
52주 최고가
₹2,039.30
52주 최저가
₹1,252.95
EPS
₹51.63
유통 주식수
1.26억
직원 수
2만
뉴스 기사
웹 소스 및 뉴스 파트너 제공
프로필
Ipca Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. The company manufactures and markets more than 350 finished-dosage formulations and around 80 active pharmaceutical ingredients, covering therapeutic areas that include pain management, rheumatology, antimalarials, cardiovascular medicine, dermatology and anti-diabetics, and has an emerging biosimilars business. Its products are sold in over 100 countries, and it is one of India's larger API exporters, supplying more than 70 countries.
Ipca is one of the largest global suppliers of the antimalarials hydroxychloroquine and chloroquine, as well as of APIs such as atenolol, chlorthalidone, losartan and metoprolol. Since 2023, it has held a majority stake in Unichem Laboratories. The company is listed on the BSE and the National Stock Exchange of India, and reported consolidated revenue of ₹9,646 crore in the financial year ended 31 March 2026. Wikipedia
IPCA Laboratories Ltd에 관한 정보